Found 23 matching trials
Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)
PHASE2Phase 2 Platform Study in Patients with Advanced Non-Small Lung Cancer who ...
Status
Active Not Recruiting
Combination of Gatipotuzumab and Tomuzotuximab in Patients With Solid Tumors
PHASE1This was a single arm phase Ib study to evaluate the safety and efficacy of...
Location
Glycotope-contracted research facility
Study of IMC-11F8 in Participants With Colorectal Cancer
PHASE2The purpose of this study is to determine if IMC-11F8 in combination with c...
Location
ImClone Investigational Site
Study of IMC-11F8 in Participants With Advanced Solid Tumors
PHASE1This study is to establish the safety and pharmacokinetic (PK) profile of I...
Location
ImClone Investigational Site
Afatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung Cancer
PHASE1This phase I trial studies the side effects and best dose of afatinib and n...
Location
City of Hope National Medical Center
A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer
PHASE1The main purpose of this study is to evaluate the safety of ramucirumab or ...
Location
Memorial Sloan Kettering Cancer Center
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin
PHASE3The research study is testing the investigational drug necitumumab in the t...
Location
ImClone Investigational Site
A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
PHASE2The main purpose of this study is to evaluate the safety and activity of th...
Location
Southern Cancer Center, P.C.
A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLC
PHASE1The main purpose of this study is to evaluate the safety and efficacy of th...
Location
Florida Cancer Specialists
A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC
PHASE2The purpose of the study is to determine if nab-paclitaxel and carboplatin ...
Location
Florida Hospital Cancer Institute